The current status of nanotechnological approaches to therapy and drug delivery in otolaryngology: A contemporary review.
drug delivery
head and neck
laryngology
nanomedicine
nanoparticles
nanotechnology
otolaryngology
otology/neurotology
Journal
Laryngoscope investigative otolaryngology
ISSN: 2378-8038
Titre abrégé: Laryngoscope Investig Otolaryngol
Pays: United States
ID NLM: 101684963
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
07
07
2022
revised:
06
10
2022
accepted:
09
10
2022
entrez:
22
12
2022
pubmed:
23
12
2022
medline:
23
12
2022
Statut:
epublish
Résumé
To summarize the current standing of nanomedicine-based technology, particularly nanoparticles (NPs), for drug delivery and diagnostic mechanisms in otolaryngology and the otolaryngology subspecialties. Literature searches were performed using PubMed and Ovid MEDLINE from 2010 to 2022. The search focused on original articles describing developments and applications of nanotechnology and drug delivery in otology, neurotology, cranial base surgery, head and neck oncology, laryngology, bronchoesophagology, and rhinology. Keyword searches and cross-referencing were also performed. No statistical analysis was performed. The PubMed search yielded 29 articles, and two Ovid MEDLINE searches both yielded 7 and 26 articles, respectively. Cross-referencing and keyword searches in PubMed and Google Scholar yielded numerous articles. The results indicate that currently, NPs are the most thoroughly studied nanotechnology for drug delivery and therapy in otolaryngology. Organic NPs have been utilized for drug delivery in otology and head and neck oncology due to their high biocompatibility. Inorganic NPs have similarly been utilized for drug delivery. However, inorganic NPs seem to be studied less extensively in these fields, likely due to an increased risk for heavy metal toxicity. Due to their magnetic properties, inorganic NPs have been utilized for magnetic-guided delivery in otology and thermoradiation and magnetic resonance imaging in head and neck oncology. Applications of nanotechnology to the fields of laryngology, bronchoesophagology, and rhinology have been studied less compared with otology and head and neck oncology. However, researchers have primarily employed NPs and other nanotechnologies such as nanofibers and nanoclusters for drug elution at mucosal surfaces to reduce airway and nasal inflammation. Nanomedicine offers potential benefits in the treatment of patients in the field of otolaryngology due to enhanced control over drug release, cell-specific targeting, and the potential to reduce drug toxicity. Future work is needed to ensure the safety of these therapies to integrate this field of research into human therapies.
Identifiants
pubmed: 36544970
doi: 10.1002/lio2.952
pii: LIO2952
pmc: PMC9764775
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1762-1772Informations de copyright
© 2022 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.
Références
Theranostics. 2012;2:113-21
pubmed: 22287991
Int J Nanomedicine. 2020 Oct 09;15:7745-7762
pubmed: 33116498
Pharmaceutics. 2020 Aug 30;12(9):
pubmed: 32872639
Int J Nanomedicine. 2011;6:535-46
pubmed: 21468356
Am J Rhinol Allergy. 2009 Nov-Dec;23(6):591-6
pubmed: 19958608
Eur J Pharm Biopharm. 2016 Feb;99:73-83
pubmed: 26690333
J Nanobiotechnology. 2021 Oct 26;19(1):342
pubmed: 34702291
Beilstein J Nanotechnol. 2018 Apr 3;9:1050-1074
pubmed: 29719757
Otol Neurotol. 2017 Sep;38(8):e224-e231
pubmed: 28806330
Carbohydr Res. 2012 Jul 1;355:40-4
pubmed: 22647542
Oncogene. 2000 Nov 20;19(49):5636-42
pubmed: 11114744
Eur J Pharm Sci. 2019 Jan 1;126:33-48
pubmed: 29933075
Nanomaterials (Basel). 2021 Mar 19;11(3):
pubmed: 33808934
Int J Nanomedicine. 2017 Sep 05;12:6461-6470
pubmed: 28919747
Acta Otorhinolaryngol Ital. 2015 Apr;35(2):97-102
pubmed: 26019393
J Exp Clin Cancer Res. 2022 Feb 4;41(1):49
pubmed: 35120582
Sci Pharm. 2013 Apr 14;81(3):843-54
pubmed: 24106677
J Pharm Sci. 2010 May;99(5):2386-98
pubmed: 19967780
Hear Res. 2011 May;275(1-2):130-8
pubmed: 21168479
J Control Release. 2011 Nov 7;155(3):344-57
pubmed: 21723891
Int Forum Allergy Rhinol. 2011 Jan-Feb;1(1):23-32
pubmed: 22287304
Chem Soc Rev. 2009 Jun;38(6):1759-82
pubmed: 19587967
Adv Mater. 2012 Jul 24;24(28):3831-7
pubmed: 22407874
J Cutan Aesthet Surg. 2010 Jan;3(1):32-3
pubmed: 20606992
Pharmaceutics. 2021 Sep 09;13(9):
pubmed: 34575513
Photodiagnosis Photodyn Ther. 2021 Dec;36:102581
pubmed: 34648994
Cancer Res. 2006 Jan 1;66(1):34-40
pubmed: 16397212
Cancer Med. 2017 Dec;6(12):2918-2931
pubmed: 29071801
J Control Release. 2016 May 28;230:26-33
pubmed: 27040816
J Nanosci Nanotechnol. 2014 Jan;14(1):755-65
pubmed: 24730295
J Hematol Oncol. 2018 Jun 20;11(1):85
pubmed: 29925404
Biomed Res Int. 2017;2017:3098230
pubmed: 29130038
Int J Nanomedicine. 2018 Sep 20;13:5561-5576
pubmed: 30271147
Otol Neurotol. 2015 Feb;36(2):341-7
pubmed: 25587675
Head Neck. 2018 Jan;40(1):70-78
pubmed: 29130566
Int J Nanomedicine. 2019 Sep 16;14:7549-7560
pubmed: 31571863
Acta Biomater. 2017 Sep 1;59:181-191
pubmed: 28688985
Eur Arch Otorhinolaryngol. 2011 Apr;268(4):489-96
pubmed: 21113606
Otol Neurotol. 2013 Jan;34(1):41-7
pubmed: 23187928
Ann Otol Rhinol Laryngol. 1971 Jun;80(3):336-41
pubmed: 5578781
Eur Arch Otorhinolaryngol. 2013 Mar;270(4):1433-9
pubmed: 22927020
Acta Biomater. 2020 May;108:46-55
pubmed: 32289495
J Nanobiotechnology. 2015 Oct 01;13:63
pubmed: 26427800
J Control Release. 2013 Mar 28;166(3):268-76
pubmed: 23313113
Int J Mol Med. 2019 Apr;43(4):1635-1642
pubmed: 30816515
Angew Chem Int Ed Engl. 2010 Aug 23;49(36):6260-6
pubmed: 20652915
J Biomater Appl. 2017 Mar;31(8):1169-1181
pubmed: 28185478
Mol Pharm. 2013 May 6;10(5):1988-97
pubmed: 23531079
Lasers Surg Med. 2011 Aug;43(6):463-9
pubmed: 21761416
J Control Release. 2014 Sep 28;190:189-200
pubmed: 24818769
Nat Nanotechnol. 2019 Nov;14(11):1007-1017
pubmed: 31695150
Otolaryngol Head Neck Surg. 2010 Jul;143(1):109-15
pubmed: 20620628
Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819853241
pubmed: 31138064
J Nanobiotechnology. 2021 May 26;19(1):157
pubmed: 34039370
Photodiagnosis Photodyn Ther. 2021 Jun;34:102218
pubmed: 33592329
Laryngorhinootologie. 2012 Jan;91(1):6-12
pubmed: 22231960
Int J Nanomedicine. 2020 Jan 20;15:347-361
pubmed: 32021184
Ann Oncol. 2008 Aug;19(8):1379-1386
pubmed: 18487549
Laryngoscope. 2018 Feb;128(2):311-316
pubmed: 28940582
Curr Opin Biotechnol. 2003 Jun;14(3):337-46
pubmed: 12849790
Nanomaterials (Basel). 2021 Mar 13;11(3):
pubmed: 33805818
Otolaryngol Head Neck Surg. 2020 Nov;163(5):923-925
pubmed: 32513065
Otol Neurotol. 2012 Jun;33(4):666-73
pubmed: 22569149
Mol Pharm. 2020 Apr 6;17(4):1276-1292
pubmed: 32142290
Small. 2011 Jan 17;7(2):169-83
pubmed: 21213377
Nanomaterials (Basel). 2015 Oct 14;5(4):1690-1703
pubmed: 28347089
Int J Oral Maxillofac Surg. 2010 Feb;39(2):174-81
pubmed: 20042316
Nanomedicine. 2018 Oct;14(7):2103-2114
pubmed: 30047470
Nanomedicine (Lond). 2012 Sep;7(9):1339-54
pubmed: 22475648
Front Cell Neurosci. 2017 Sep 13;11:268
pubmed: 28955202
Otol Neurotol. 2010 Sep;31(7):1115-21
pubmed: 20616758
Hear Res. 2010 Oct 1;269(1-2):1-11
pubmed: 20659540
Nanomaterials (Basel). 2021 May 17;11(5):
pubmed: 34067544
Res Pharm Sci. 2015 Jan-Feb;10(1):1-16
pubmed: 26430453
Iran Biomed J. 2016;20(1):1-11
pubmed: 26286636
Head Neck. 2014 Jul;36(7):976-84
pubmed: 23733258
J Otolaryngol Head Neck Surg. 2020 Jul 6;49(1):46
pubmed: 32631452
Materials (Basel). 2021 Jul 02;14(13):
pubmed: 34279276
Laryngoscope. 2008 Apr;118(4):706-11
pubmed: 18182968
J Am Chem Soc. 2014 Dec 3;136(48):16712-5
pubmed: 25407895
Front Oncol. 2021 May 07;11:640392
pubmed: 34026617
Biomater Sci. 2018 Dec 18;7(1):196-210
pubmed: 30422139
Adv Drug Deliv Rev. 2017 Jan 1;108:2-12
pubmed: 26796230
Mol Syst Biol. 2013;9:636
pubmed: 23340842
Eur Arch Otorhinolaryngol. 2015 Aug;272(8):1825-31
pubmed: 24927828
Clin Exp Otorhinolaryngol. 2011 Mar;4(1):1-10
pubmed: 21461056
Phytomedicine. 2019 Mar 15;56:215-228
pubmed: 30668343
ACS Nano. 2015 Jan 27;9(1):991-1003
pubmed: 25559017
Oncologist. 2010;15(9):994-1001
pubmed: 20798198
Oral Oncol. 2020 Jul;106:104689
pubmed: 32330686
Cancer Res. 2013 Mar 15;73(6):1855-66
pubmed: 23319806
Oncotarget. 2015 Jul 30;6(21):18504-17
pubmed: 26098778
Oral Oncol. 2021 Apr;115:105184
pubmed: 33581504
Otolaryngol Head Neck Surg. 2007 Oct;137(4):619-23
pubmed: 17903580
Nat Commun. 2014 Jun 25;5:4182
pubmed: 24964370
Chem Soc Rev. 2018 Nov 26;47(23):8572-8610
pubmed: 30177983
J Biomed Mater Res B Appl Biomater. 2016 Feb;104(2):274-82
pubmed: 25716009
Int J Pharm. 2012 May 30;428(1-2):164-70
pubmed: 22421322
J Otol. 2016 Dec;11(4):165-177
pubmed: 29937826
Acta Biochim Pol. 2020 Jun 8;67(2):149-155
pubmed: 32506868
Methods Mol Biol. 2016;1427:363-415
pubmed: 27259938
Otolaryngol Clin North Am. 2005 Apr;38(2):273-93, vi
pubmed: 15823593
J Tissue Eng. 2022 Mar 23;13:20417314221083414
pubmed: 35340424
ACS Nano. 2019 Nov 26;13(11):13382-13389
pubmed: 31603304
Ann Surg Oncol. 2013 Sep;20(9):3076-82
pubmed: 23686100
J Control Release. 2018 Feb 28;272:54-61
pubmed: 29331580
ACS Appl Bio Mater. 2021 May 17;4(5):4131-4139
pubmed: 35006827
Adv Drug Deliv Rev. 1998 Jan 5;29(1-2):13-38
pubmed: 10837578